Senators seek to end patent settlements

07/24/2013 | Bloomberg Businessweek

Sens. Charles Grassley, R-Iowa, and Amy Klobuchar, D-Minn., said at a Senate hearing Tuesday that they hope to eliminate patent settlements between brand-name drugmakers and manufacturers of generic drugs. Grassley and Klobuchar's measure would make patent settlements unlawful unless drugmakers can show they are not anti-competitive. Klobuchar said "it's simply outrageous that consumers are forced to pay higher prices for critical drugs because of brand companies colluding with generic competitors."

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA